Leading the way, this is the only industry-dedicated forum placing donor testing, screening, retention and cell source selection in the main spotlight to drive scalable allogeneic manufacturing development and streamline both supply chain and process development.
Last year saw an end-to-end meeting, bringing together an exclusive forum of leaders within R&D, CMC, manufacturing, supply chain, process development and analytics that are working to define gold standard approaches for donor characterization, testing and cell source procurement for safe and globally accessible off-the-shelf cell therapies.